4-56467656-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_006947.4(SRP72):c.21G>T(p.Gly7Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 1,555,988 control chromosomes in the GnomAD database, including 35,055 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.19 ( 3286 hom., cov: 31)
Exomes 𝑓: 0.21 ( 31769 hom. )
Consequence
SRP72
NM_006947.4 synonymous
NM_006947.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.112
Genes affected
SRP72 (HGNC:11303): (signal recognition particle 72) This gene encodes the 72 kDa subunit of the signal recognition particle (SRP), a ribonucleoprotein complex that mediates the targeting of secretory proteins to the endoplasmic reticulum (ER). The SRP complex consists of a 7S RNA and 6 protein subunits: SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72, that are bound to the 7S RNA as monomers or heterodimers. SRP has at least 3 distinct functions that can be associated with the protein subunits: signal recognition, translational arrest, and ER membrane targeting by interaction with the docking protein. Mutations in this gene are associated with familial bone marrow failure. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 4-56467656-G-T is Benign according to our data. Variant chr4-56467656-G-T is described in ClinVar as [Benign]. Clinvar id is 349114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-56467656-G-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.112 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRP72 | NM_006947.4 | c.21G>T | p.Gly7Gly | synonymous_variant | 1/19 | ENST00000642900.1 | NP_008878.3 | |
SRP72 | NM_001267722.2 | c.21G>T | p.Gly7Gly | synonymous_variant | 1/17 | NP_001254651.1 | ||
SRP72 | XM_024454192.2 | c.21G>T | p.Gly7Gly | synonymous_variant | 1/17 | XP_024309960.1 | ||
SRP72 | NR_151856.2 | n.40G>T | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRP72 | ENST00000642900.1 | c.21G>T | p.Gly7Gly | synonymous_variant | 1/19 | NM_006947.4 | ENSP00000495128.1 | |||
SRP72 | ENST00000510663.6 | c.21G>T | p.Gly7Gly | synonymous_variant | 1/17 | 1 | ENSP00000424576.1 | |||
SRP72 | ENST00000504757.2 | c.21G>T | p.Gly7Gly | synonymous_variant | 1/5 | 2 | ENSP00000473576.1 |
Frequencies
GnomAD3 genomes AF: 0.195 AC: 29544AN: 151828Hom.: 3272 Cov.: 31
GnomAD3 genomes
AF:
AC:
29544
AN:
151828
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.232 AC: 45960AN: 197836Hom.: 6443 AF XY: 0.224 AC XY: 24645AN XY: 109860
GnomAD3 exomes
AF:
AC:
45960
AN:
197836
Hom.:
AF XY:
AC XY:
24645
AN XY:
109860
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.205 AC: 288364AN: 1404042Hom.: 31769 Cov.: 32 AF XY: 0.205 AC XY: 143168AN XY: 697074
GnomAD4 exome
AF:
AC:
288364
AN:
1404042
Hom.:
Cov.:
32
AF XY:
AC XY:
143168
AN XY:
697074
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.195 AC: 29571AN: 151946Hom.: 3286 Cov.: 31 AF XY: 0.201 AC XY: 14955AN XY: 74268
GnomAD4 genome
AF:
AC:
29571
AN:
151946
Hom.:
Cov.:
31
AF XY:
AC XY:
14955
AN XY:
74268
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
924
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 14, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Autosomal dominant aplasia and myelodysplasia Benign:3
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 30, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at